Cargando…

Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics

The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alternative treatment options, and this has led to renewed interest in phage therapy. In this respect, we describe the distinct host ranges of Staphylococcus phage K, and two other K-like phages against...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajuebor, Jude, Buttimer, Colin, Arroyo-Moreno, Sara, Chanishvili, Nina, Gabriel, Emma M., O’Mahony, Jim, McAuliffe, Olivia, Neve, Horst, Franz, Charles, Coffey, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022877/
https://www.ncbi.nlm.nih.gov/pubmed/29693603
http://dx.doi.org/10.3390/antibiotics7020037
_version_ 1783335754001285120
author Ajuebor, Jude
Buttimer, Colin
Arroyo-Moreno, Sara
Chanishvili, Nina
Gabriel, Emma M.
O’Mahony, Jim
McAuliffe, Olivia
Neve, Horst
Franz, Charles
Coffey, Aidan
author_facet Ajuebor, Jude
Buttimer, Colin
Arroyo-Moreno, Sara
Chanishvili, Nina
Gabriel, Emma M.
O’Mahony, Jim
McAuliffe, Olivia
Neve, Horst
Franz, Charles
Coffey, Aidan
author_sort Ajuebor, Jude
collection PubMed
description The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alternative treatment options, and this has led to renewed interest in phage therapy. In this respect, we describe the distinct host ranges of Staphylococcus phage K, and two other K-like phages against 23 isolates, including 21 methicillin-resistant S. aureus (MRSA) representative sequence types representing the Irish National MRSA Reference Laboratory collection. The two K-like phages were isolated from the Fersisi therapeutic phage mix from the Tbilisi Eliava Institute, and were designated B1 (vB_SauM_B1) and JA1 (vB_SauM_JA1). The sequence relatedness of B1 and JA1 to phage K was observed to be 95% and 94% respectively. In terms of host range on the 23 Staphylococcus isolates, B1 and JA1 infected 73.9% and 78.2% respectively, whereas K infected only 43.5%. Eleven open reading frames (ORFs) present in both phages B1 and JA1 but absent in phage K were identified by comparative genomic analysis. These ORFs were also found to be present in the genomes of phages (Team 1, vB_SauM-fRuSau02, Sb_1 and ISP) that are components of several commercial phage mixtures with reported wide host ranges. This is the first comparative study of therapeutic staphylococcal phages within the recently described genus Kayvirus.
format Online
Article
Text
id pubmed-6022877
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60228772018-07-02 Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics Ajuebor, Jude Buttimer, Colin Arroyo-Moreno, Sara Chanishvili, Nina Gabriel, Emma M. O’Mahony, Jim McAuliffe, Olivia Neve, Horst Franz, Charles Coffey, Aidan Antibiotics (Basel) Article The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alternative treatment options, and this has led to renewed interest in phage therapy. In this respect, we describe the distinct host ranges of Staphylococcus phage K, and two other K-like phages against 23 isolates, including 21 methicillin-resistant S. aureus (MRSA) representative sequence types representing the Irish National MRSA Reference Laboratory collection. The two K-like phages were isolated from the Fersisi therapeutic phage mix from the Tbilisi Eliava Institute, and were designated B1 (vB_SauM_B1) and JA1 (vB_SauM_JA1). The sequence relatedness of B1 and JA1 to phage K was observed to be 95% and 94% respectively. In terms of host range on the 23 Staphylococcus isolates, B1 and JA1 infected 73.9% and 78.2% respectively, whereas K infected only 43.5%. Eleven open reading frames (ORFs) present in both phages B1 and JA1 but absent in phage K were identified by comparative genomic analysis. These ORFs were also found to be present in the genomes of phages (Team 1, vB_SauM-fRuSau02, Sb_1 and ISP) that are components of several commercial phage mixtures with reported wide host ranges. This is the first comparative study of therapeutic staphylococcal phages within the recently described genus Kayvirus. MDPI 2018-04-25 /pmc/articles/PMC6022877/ /pubmed/29693603 http://dx.doi.org/10.3390/antibiotics7020037 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ajuebor, Jude
Buttimer, Colin
Arroyo-Moreno, Sara
Chanishvili, Nina
Gabriel, Emma M.
O’Mahony, Jim
McAuliffe, Olivia
Neve, Horst
Franz, Charles
Coffey, Aidan
Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
title Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
title_full Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
title_fullStr Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
title_full_unstemmed Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
title_short Comparison of Staphylococcus Phage K with Close Phage Relatives Commonly Employed in Phage Therapeutics
title_sort comparison of staphylococcus phage k with close phage relatives commonly employed in phage therapeutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022877/
https://www.ncbi.nlm.nih.gov/pubmed/29693603
http://dx.doi.org/10.3390/antibiotics7020037
work_keys_str_mv AT ajueborjude comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT buttimercolin comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT arroyomorenosara comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT chanishvilinina comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT gabrielemmam comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT omahonyjim comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT mcauliffeolivia comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT nevehorst comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT franzcharles comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics
AT coffeyaidan comparisonofstaphylococcusphagekwithclosephagerelativescommonlyemployedinphagetherapeutics